Stocks to Watch: Dr Reddy's, HUL, NCC in Focus; Sensex Expiry to Drive Volatility

• Dr Reddy's acquires Progynova and Cyclo-Progynova trademarks in India for $32.1 million.
• HUL to invest ₹2000 crore over two years to boost manufacturing capacity in premium categories.
• Zydus Lifesciences receives US FDA approval for 32 mg Bosentan tablets for Pulmonary Arterial Hypertension.
• NCC and its subsidiary OB Infrastructure banned for two years from NHAI tenders.
• Cochin Shipyard secures over ₹2,000 crore contract from CMA CGM for six LNG-powered container vessels.